Abstract
The pharmacologic approaches currently in clinical use have remained unsatisfactory in preventing the cardiac complications associated with diabetes and more innovative therapies are needed. The advanced glycation products (AGEs) formation is an important pathway involved in diabetic cardiomyopathy. In addition, the epicardial adipose tissue (EAT) secretes and expresses adipokines, which …